KAN-004

· Centre hospitalier de l'Université de Montréal (CHUM)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KAN-004, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: KAN-004 for Immune-Related Diarrhea or Colitis [Phase 1]